Analysis of efficacy and safety of drotrecogin alfa (activated) in surgical patients, using an international integrated database.
Payen
Didier
D
Sundin
David P
DP
Nelson
David R
DR
Williams
Mark D
MD
D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D019992:Databases as Topic; D006801:Humans; D015999:Multivariate Analysis; D016017:Odds Ratio; D019106:Postoperative Hemorrhage / Q000209:etiology; D011486:Protein C / Q000009:adverse effects / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors; D013530:Surgical Wound Infection / Q000401:mortality / Q000517:prevention & control*
D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated